Algohary, A.; Alhusseini, M.; Breto, A.L.; Kwon, D.; Xu, I.R.; Gaston, S.M.; Castillo, P.; Punnen, S.; Spieler, B.; Abramowitz, M.C.;
et al. Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy. Cancers 2022, 14, 4475.
https://doi.org/10.3390/cancers14184475
AMA Style
Algohary A, Alhusseini M, Breto AL, Kwon D, Xu IR, Gaston SM, Castillo P, Punnen S, Spieler B, Abramowitz MC,
et al. Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy. Cancers. 2022; 14(18):4475.
https://doi.org/10.3390/cancers14184475
Chicago/Turabian Style
Algohary, Ahmad, Mohammad Alhusseini, Adrian L. Breto, Deukwoo Kwon, Isaac R. Xu, Sandra M. Gaston, Patricia Castillo, Sanoj Punnen, Benjamin Spieler, Matthew C. Abramowitz,
and et al. 2022. "Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy" Cancers 14, no. 18: 4475.
https://doi.org/10.3390/cancers14184475
APA Style
Algohary, A., Alhusseini, M., Breto, A. L., Kwon, D., Xu, I. R., Gaston, S. M., Castillo, P., Punnen, S., Spieler, B., Abramowitz, M. C., Dal Pra, A., Kryvenko, O. N., Pollack, A., & Stoyanova, R.
(2022). Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy. Cancers, 14(18), 4475.
https://doi.org/10.3390/cancers14184475
